Organisation paid for research Program year 2024 Source: CMS Open Payments

Compass Point Research

Neither a doctor nor a teaching hospital

Research payments

$32,732

612 payments

Through program year 2024, Compass Point Research is reported as receiving $32,732 in research payments, across 612 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $29,202 610
2023 Research $30 1
2020 Research $3,500 1

Breakdown

Who paid Research payments · program years 2020–2024
  1. Novo Nordisk AS $28,661 610 payments
  2. Eli Lilly and Company $4,071 2 payments
Studies the money was for Research payments · program years 2020–2024
  1. Nn9535-4801 $28,661 610 payments
  2. A Randomized, Controlled Pragmatic Phase 3B/4 Study of Baricitinib in Patients With Rheumatoid Arthritis $3,500 1 payment
  3. A Study of Retatrutide (Ly3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity Or Overweight (Triumph-2) $571 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record